Fatigue Is Associated With Serum Interleukin-6 Levels and Symptoms of Depression in Patients on Chronic Hemodialysis

被引:97
|
作者
Bossola, Maurizio [1 ]
Di Stasio, Enrico [2 ]
Giungi, Stefania [1 ]
Rosa, Fausto [1 ]
Tazza, Luigi [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Div Transplantat & Dialysis, Hemodialysis Serv, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Clin Chem, I-00168 Rome, Italy
关键词
Hemodialysis; fatigue; inflammation; interleukin-6; depression; C-REACTIVE PROTEIN; QUALITY-OF-LIFE; RHEUMATOID-ARTHRITIS; SYSTEMIC INFLAMMATION; CANCER-PATIENTS; DIALYSIS; DISEASE; STRESS; TOCILIZUMAB; ACTIVATION;
D O I
10.1016/j.jpainsymman.2014.07.009
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context. Little is known about activated immune-inflammatory pathways and interleukin-6 (IL-6) in the development of fatigue and/or depression in patients with end-stage renal disease on chronic hemodialysis (HD). Objectives. To evaluate the possible correlation between fatigue and serum levels of IL-6 in patients on chronic HD. Methods. One hundred HD patients were assessed for the presence of fatigue using the SF-36 Vitality subscale and were administered the Beck Depression Inventory (BDI), the Hamilton Anxiety Rating Scale (HARS), the Mini-Mental State Examination (MMSE), the activities of daily living (ADL), and the instrumental activities of daily living (IADL). We also calculated the time of recovery after hemodialysis (TIRD) and the number/severity of comorbidities using the Charlson Comorbidity Index (CCI). Laboratory parameters were measured as well as serum IL-6. Results. Forty-three patients constituted the fatigued group and 57 the nonfatigued group. Age, CCI, BDI, HARS, and TIRD were significantly higher in fatigued patients than in the nonfatigued patients. Conversely, the scores of ADL, IADL, and MMSE were significantly lower in fatigued than in nonfatigued patients. Serum IL-6 levels (pg/mL) were higher in the fatigued group (5.1 +/- 3.4) than in the nonfatigued group (1.6 +/- 1.5; P < 0.001); serum albumin and creatinine levels were significantly lower. Twenty-six patients (26%) had no symptoms of depression (BDI score < 10), and 74 patients (74%) had symptoms of depression (BDI score > 9). Patients with a BDI score > 9 were older; had a higher CCI; a lower MMSE; a higher TIRD; lower serum albumin, creatinine, and urea levels; and higher serum IL-6 levels. The correlation analyses showed that the score of the SF-36 Vitality subscale was associated with age, dialytic age, TIRD, ADL, IADL, CCI, BDI, HARS, MMSE, serum urea, creatinine, albumin, and IL-6 levels. On multivariate general linear model analyses, with fatigue as the dependent variable and gender as a second factor, BDI and serum IL-6 levels were independently associated with the score of the SF-36 Vitality subscale. A canonical correlation analysis was performed including in the model fatigue, BDI, and biomarkers; the correlation was 0.679 (R-2 = 0.462). Fatigue, BDI, and IL-6 among biomarkers showed the strongest association with the underlying construct (standardized canonical coefficients = -0.989, 0.015, and 0.852, respectively), thus explaining a correlation of IL-6 with both depression and fatigue. Conclusion. Fatigue was significantly associated with symptoms of depression and serum IL-6 levels in patients receiving chronic HD. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:578 / 585
页数:8
相关论文
共 50 条
  • [21] INTERLEUKIN-6 SERUM LEVELS IN PATIENTS WITH GYNECOLOGICAL TUMORS
    SCAMBIA, G
    TESTA, U
    PANICI, PB
    MARTUCCI, R
    FOTI, E
    PETRINI, M
    AMOROSO, M
    MASCIULLO, V
    PESCHLE, C
    MANCUSO, S
    INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) : 318 - 323
  • [22] Serum interleukin-6 levels in patients with biliary obstruction
    Kimura, F
    Miyazaki, M
    Suwa, T
    Sugiura, T
    Shinoda, T
    Itoh, H
    Ambiru, S
    Shimizu, H
    Nakagawa, K
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1613 - 1617
  • [23] Interleukin-6 may mediate malnutrition in chronic hemodialysis patients
    Kaizu, Y
    Kimura, M
    Yoneyama, T
    Miyaji, K
    Hibi, I
    Kumagai, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (01) : 93 - 100
  • [24] Interleukin-6 gene polymorhisms and interleukin-6 levels are associated with atherosclerosis in CKD patients
    Hassan, Muzamil Olamide
    Duarte, Raquel
    Dickens, Caroline
    Dix-Peek, Therese
    Naidoo, Sagren
    Vachiat, Ahmed
    Grinter, Sacha
    Manga, Pravin
    Naicker, Saraladevi
    CLINICAL NEPHROLOGY, 2020, 93 (07) : S82 - S86
  • [25] Are Serum Lipid Levels Associated With Depression in Hemodialysis Patients?
    Sahin, Idris
    Kiran, Umit Kemal
    Sahin, Huseyin Avni
    Ustun, Yusuf
    Agargun, Mehmet Yucel
    Erkoc, Reha
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2006, 15 (02): : 106 - 110
  • [26] Acute phase proteins and interleukin-6 serum levels in patients with chronic arterial occlusion
    Majewski, W
    Staniszewski, R
    Slupianek, A
    Gorny, A
    Mackiewicz, A
    INTERLEUKIN-6 TYPE CYTOKINES, 1995, 762 : 493 - 495
  • [27] Analysis of Serum Interleukin-6 in Patients with Depression by Emotional Counselling
    Zhang, Z. Y.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 81 (01) : S19 - S19
  • [28] Serum Levels of Interleukin-6 and Interleukin-10 in Relation to Depression Scores in Patients with Cardiovascular Risk Factors
    Meyer, Thomas
    Stanske, Beate
    Kochen, Michael M.
    Cordes, Andreas
    Yueksel, Iraz
    Wachter, Rolf
    Lueers, Claus
    Scherer, Martin
    Binder, Lutz
    Pieske, Burkert
    Herrmann-Lingen, Christoph
    BEHAVIORAL MEDICINE, 2011, 37 (03) : 105 - 112
  • [29] Kinetics of serum hepcidin and interleukin-6 levels following COVID-19 infection in hemodialysis patients
    Touzot, Maxime
    Lefebvre, Thibaud
    Maheas, Catherine
    Peoc'h, Katell
    Urena-Torres, Pablo
    Ridel, Christophe
    Puy, Herve
    Karim, Zoubida
    CLINICAL KIDNEY JOURNAL, 2022, 15 (03) : 582 - 583
  • [30] Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
    Robak, T
    Gladalska, A
    Stepien, H
    Robak, E
    MEDIATORS OF INFLAMMATION, 1998, 7 (05) : 347 - 353